O'Neil; Steven Victor

Patent Applications and Registrations

Patent applications and USPTO patent grants for O'Neil; Steven Victor.The latest application filed is for "heterocyclic spiro compounds as magl inhibitors".

Company Profile

14.24.33

O'Neil; Steven Victor - East Lyme CT
O'Neil; Steven Victor - Clinton CT
O'Neil; Steven Victor - Morrow OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic Spiro Compounds As MAGL Inhibitors App 20210309669 - Brodney; Michael Aaron ; et al.	2021-10-07
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20210300899 - Brodney; Michael Aaron ; et al.	2021-09-30
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 11,014,909 - Brodney , et al. May 25, 2	2021-05-25
Heterocyclic spiro compounds as MAGL inhibitors Grant 10,858,373 - Brodney , et al. December 8, 2	2020-12-08
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20200283407 - Brodney; Michael Aaron ; et al.	2020-09-10
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Grant 10,723,711 - Butler , et al.	2020-07-28
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,696,658 - Brodney , et al. June 30, 2	2020-06-30
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors Grant 10,626,125 - Brodney , et al.	2020-04-21
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl App 20190382359 - BUTLER; CHRISTOPHER RYAN ; et al.	2019-12-19
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20190367485 - Brodney; Michael Aaron ; et al.	2019-12-05
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Grant 10,428,034 - Butler , et al. October 1, 2	2019-10-01
Heterocyclic Spiro Compounds As Magl Inhibitors App 20190292203 - Brodney; Michael Aaron ; et al.	2019-09-26
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,421,744 - Brodney , et al. Sept	2019-09-24
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives As Magl Inhibitors App 20190276472 - BRODNEY; MICHAEL AARON ; et al.	2019-09-12
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors Grant 10,329,308 - Brodney , et al.	2019-06-25
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20190002439 - BRODNEY; MICHAEL AARON ; et al.	2019-01-03
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180346477 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2018-12-06
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,093,655 - Brodney , et al. October 9, 2	2018-10-09
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 10,077,272 - Gray , et al. September 18, 2	2018-09-18
Heterocyclic Spiro Compounds As Magl Inhibitors App 20180208608 - BRODNEY; MICHAEL AARON ; et al.	2018-07-26
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives As Magl Inhibitors App 20180208607 - BRODNEY; MICHAEL AARON ; et al.	2018-07-26
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20180200253 - COE; JOTHAM WADSWORTH ; et al.	2018-07-19
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180072750 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2018-03-15
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl Inhibitors App 20180065943 - BUTLER; CHRISTOPHER RYAN ; et al.	2018-03-08
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20180037571 - BRODNEY; MICHAEL AARON ; et al.	2018-02-08
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,868,744 - Gray , et al. January 16, 2	2018-01-16
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Grant 9,845,301 - Butler , et al. December 19, 2	2017-12-19
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,822,097 - Brodney , et al. November 21, 2	2017-11-21
Heterocyclic compounds and their use as dopamine D1 ligands Grant 9,745,317 - Gray , et al. August 29, 2	2017-08-29
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20170165270 - COE; JOTHAM WADSWORTH ; et al.	2017-06-15
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,617,275 - Coe , et al. April 11, 2	2017-04-11
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20170057947 - BRODNEY; MICHAEL AARON ; et al.	2017-03-02
Heterocyclic Compounds And Their Use As Dopamine D1 Ligands App 20170044174 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2017-02-16
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20170037053 - GRAY; DAVID LAWRENCE FIRMAN ; et al.	2017-02-09
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl Inhibitors App 20170029390 - BUTLER; CHRISTOPHER RYAN ; et al.	2017-02-02
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,527,843 - Davoren , et al. December 27, 2	2016-12-27
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,527,831 - Brodney , et al. December 27, 2	2016-12-27
Pyridine Derivatives As Muscarinic M1 Receptor Positive Allosteric Modulators App 20160016907 - BRODNEY; MICHAEL AARON ; et al.	2016-01-21
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20150344490 - COE; JOTHAM WADSWORTH ; et al.	2015-12-03
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150344474 - DAVOREN; JENNIFER ELIZABETH ; et al.	2015-12-03
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20150291625 - COE; JOTHAM WADSWORTH ; et al.	2015-10-15
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,139,561 - Brodney , et al. September 22, 2	2015-09-22
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,133,190 - Davoren , et al. September 15, 2	2015-09-15
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 9,107,923 - Brodney , et al. August 18, 2	2015-08-18
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150196561 - BRODNEY; MICHAEL AARON ; et al.	2015-07-16
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150175573 - BRODNEY; MICHAEL AARON ; et al.	2015-06-25
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20150005313 - BRODNEY; MICHAEL AARON ; et al.	2015-01-01
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20140336176 - DAVOREN; JENNIFER ELIZABETH ; et al.	2014-11-13
Heteroaromatic compounds and their use as dopamine D1 ligands Grant 8,822,494 - Davoren , et al. September 2, 2	2014-09-02
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands App 20140128374 - DAVOREN; JENNIFER ELIZABETH ; et al.	2014-05-08
Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5) App 20100273772 - O'Neil; Steven Victor ; et al.	2010-10-28
Interleukin-1.beta. converting enzyme inhibitors Grant 7,138,395 - O'Neil , et al. November 21, 2	2006-11-21
Interleukin-1.beta. converting enzyme inhibitors Grant 7,041,696 - Wos , et al. May 9, 2	2006-05-09
Interleukin converting enzyme inhibitors Grant 7,001,899 - Wos , et al. February 21, 2	2006-02-21
Novel interleukin-1beta converting enzyme inhibitors App 20040014753 - O'Neil, Steven Victor ; et al.	2004-01-22
Interleukin converting enzyme inhibitors App 20040009966 - Wos, John August ; et al.	2004-01-15
Novel interleukin-1beta converting enzyme inhibitors App 20030236296 - Wos, John August ; et al.	2003-12-25